Among postmenopausal women in the Women’s Health Initiative trials, use of HRT for 5 to 7 years was not associated with risk of all-cause, cardiovascular or cancer death over 18 years of follow-up, according to a study published by JAMA. Click here to read more The RCOG and the BMS have issued a comment on [...]
The Faculty of Sexual and Reproductive Healthcare has updated its guideline on contraception in the over 40s. In particular, clarification has been provided around contraception around the perimenopause and also the use of HRT alongside contraception. Read more here (opens in separate window)
Advertising Standards Association ruling on ‘misleading’ promotion of bioidentical hormone replacement therapy
The British Menopause Society issued a consensus statement in March 2017 regarding the safety of custom-compounded bioidentical hormones: “Trustees and Members of the Medical Advisory Council of the British Menopause Society are concerned about the safety of unregulated compounded bioidentical hormonal therapy which is being prescribed by clinicians who do not usually have any recognised [...]
Kathy Abernethy, the new BMS chairman, said: “Hormone replacement therapy (HRT) is absolutely the best treatment for hot flushes and sweats that affect daily life. It can also help sleep disturbance caused by night sweats and is one of several strategies to keep bones strong.” Read the article: https://www.theguardian.com/lifeandstyle/2017/aug/07/hrt-and-vaginal-moisturisers-heres-what-really-helps-menopausal-women
A paper published today in Menopause, the journal of the North American Menopause Society, reports that Postmenopausal Hormone Replacement Therapy may be associated with a higher risk of hearing loss. Click here to read press release (opens in Word) Dr Heather Currie, chairman of the British Menopause Society, commented: ‘This type of trial relies on women’s [...]
Just in case you missed these two excellent TV programmes last Thursday, 20 April, here are the links.
This documentary features Dr Heather Currie, Chair of the British Menopause Society (BMS). The British Menopause Society and the Royal College of Obstetricians and Gynaecologists (RCOG) have issued a statement ahead of the screening.
Trustees and Members of the Medical Advisory Council of the British Menopause Society are concerned about the safety of unregulated bioidentical hormonal therapy which is being prescribed by clinicians who do not usually have any recognised menopause training and provided from compounding pharmacies.
After accounting for age, coronary calcium score and cardiovascular risk factors including diabetes, high blood pressure and high cholesterol, women using hormone replacement therapy were overall 30 percent less likely to die than those not on hormone therapy.
A new paper from Professor Robert D Langer demonstrates that WHI Study errors led to 15 years of unnecessary suffering for women
Professor Langer reveals that the WHI study did not show any statistically significant increased risk of breast cancer or heart disease in women using HRT, yet the highly publicised conclusions emphasised these risks.